BIOTRONIK‘s Lumax 540 implantable cardiac defibrillators will now be able to provide Thoracic Impedance (TI) Trend Charting as part of its wireless reporting via the company’s Heart Failure Monitor.
Preclinical and clinical research have proven that TI is correlated with a patient’s lung fluid volume, – a variable that is related to heart failure (HF) status. By now being able to identify changes in TI, physicians have more information that can help them to act appropriately to prevent HF progression.
The TI Trend Chart displays variations in TI on a daily basis and is a diagnostic enhancement to the BIOTRONIK Heart Failure Monitor®. The Heart Failure Monitor is a part of BIOTRONIK Home Monitoring and displays graphics for variables such as cardiac resynchronization therapy (CRT) pacing, heart rate, patient activity and arrhythmias. Importantly, it is also configured to trigger any necessary alert notifications to the patient’s physician on a daily basis, based on relevant changes in HF status.